MCC950
| 规格 | 价格 | 货期 | 数量 |
|---|---|---|---|
| 10mg | 请咨询 | 请咨询 |
特色产品
- 用于免疫印迹和质谱分析等后续操作
- 适用于30 KDa-130 KDa大小的蛋白
- 可将信号灵敏度提高100倍
- 同时保持稳定的特异性和分辨率
- 提供更高的转录效率并抑制免疫激活
- 使用5-moUTP和Cy5-utp修饰
产品描述
MCC950 is a selective inhibitor of NLRP3 with IC50 of 7.5 nm. It does not inhibit NLRC4, AIM2, TLR2 signaling, or priming of NLRP3.
MCC950 inhibits IL-1β in a dose-dependent manner, but cannot inhibit TNF-α secretion. When stimulating non-standard pathways, MCC950 specifically blocks NLRP3 activation and IL-1β secretion guided by caspase-11. Even at a concentration of 10 μM, MCC950 does not inhibit NLRC4 stimulated IL-1β and TNF-α.
MCC-950 is active in vivo, blocking the production of IL-1β and enhancing survival in mouse models of multiple sclerosis and cryopyrin-associated periodic syndrome.
Reference:
[1]. Coll R C, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med, 2015, 21(3): 248-55.
产品性质
| 物理外观 | A crystalline solid |
| CAS号 | 210826-40-7 |
| 分子式 | C20H24N2O5S |
| 分子量 | 404.48 |
| 化学名称 | N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide |
| 溶解度 | ≤0.5mg/ml in ethanol;30mg/ml in DMSO;30mg/ml in dimethyl formamide |
| SMILES | O=S(NC(NC1=C(CCC2)C2=CC3=C1CCC3)=O)(C4=CC(C(C)(O)C)=CO4)=O |
| 存储条件 | -20°C |
| 运输条件 | 蓝冰 |
产品应用 (实验数据来自文献,APExBIO并未验证,仅供参考)
IC50和靶点
| 生物活性描述 | MCC950(CP-456773;CRID3)是一种强效的选择性 NLRP3 抑制剂,在 BMDMs 和 HMDMs 中的 IC50 分别为 7.5 和 8.1 nM。 |
生物相关数据
质量控制
操作说明
APExBIO 顾客使用本产品发表的 14 篇科研文献
8. Xingyu FAN, Xiao-qian LIAO, et al. "Shenfu Injection Regulates Pyroptosis through the NLRP3/Caspase-1 Pathway to Improve Chronic Heart Failure." Research Square. 14 Sep, 2023
13. Yang Yang, Pianpian Xu, et al. "Mycobacterial PPE13 activates inflammasome by interacting with the NATCH and LRR domains of NLRP3." The FASEB Journal. 2020;00:1–14



沪公网安备 31011002003500